Form 4: Immuneering Corp Director Thomas J. Schall Acquires Stock Options
SEC Form 4 Filing
Director Thomas J. Schall acquired stock options in Immuneering Corp on June 12, 2024.
Summary
- On June 12, 2024, Thomas J. Schall, a director of Immuneering Corp, acquired 8,588 stock options at a price of $1.54.
- These options vest in equal monthly installments over one year, starting July 12, 2024, and will be fully vested by June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.
- Following the transaction, Schall directly owns 8,588 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. The acquisition itself can be seen as a slightly positive signal, but the filing is primarily informational.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Thomas J. Schall acquired stock options. |
| 07/12/2024 | Vesting start date: Options vest in equal monthly installments over a one-year period commencing on this date. |
| 06/12/2025 | Full vesting date: Options will be fully vested and exercisable on this date, or the date of the 2025 annual meeting of stockholders, whichever comes first. |
| 06/13/2024 | Date of report: Filing date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.